Allina Health System
Allina Health System was paid $4.22M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
HASTINGS, MN 55033
Next to other Clinic/Center providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,872 | $175K | |
| 2019 | 17,332 | $610K | |
| 2020 | 15,663 | $608K | |
| 2021 | 20,391 | $850K | |
| 2022 | 16,068 | $713K | |
| 2023 | 14,909 | $709K | |
| 2024incomplete | 10,326 | $553K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 31,164 | 28,178 | $1.55M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 22,185 | 20,040 | $1.53M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.7% | 1,976 | 1,915 | $155K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.7% | 2,387 | 1,372 | $155K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.8% | 4,133 | 4,063 | $120K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.4% | 788 | 694 | $102K |
| X5622 | 1.8% | 1,916 | 1,879 | $76K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 691 | 679 | $50K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,729 | 1,675 | $40K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,899 | 11,575 | $38K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 6,051 | 5,953 | $36K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 453 | 449 | $35K |
55 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,047 | $34K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 340 | $28K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 280 | $28K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 807 | $28K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,895 | $23K |
| 92015 | Determination of refractive state | <1% | 1,740 | $21K |
| 92551 | <1% | 2,663 | $19K | |
| 90686 | <1% | 3,590 | $18K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,390 | $16K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 165 | $12K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 141 | $10K |
| 99188 | <1% | 1,028 | $8K | |
| 80061 | Lipid panel | <1% | 760 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 883 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 324 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 385 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 630 | $6K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 119 | $5K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 198 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 669 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 494 | $4K |
| 99417 | Prolong home eval add 15m | <1% | 75 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 19 | $3K |
| 99173 | <1% | 2,364 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 27 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 67 | $2K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 13 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 53 | $2K |
| 90656 | <1% | 130 | $1K | |
| 90670 | <1% | 145 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $1K |
| 90651 | <1% | 74 | $1K | |
| 96127 | <1% | 251 | $937.91 | |
| 0004A | <1% | 41 | $868.28 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 93 | $712.95 |
| 87081 | <1% | 226 | $698.37 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 74 | $686.04 |
| 81001 | <1% | 240 | $685.66 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 120 | $657.92 |
| 99442 | <1% | 63 | $636.29 | |
| 0001A | <1% | 15 | $598.78 | |
| G0008 | Administration of influenza virus vaccine | <1% | 177 | $561.20 |
| V2020 | Frames, purchases | <1% | 16 | $514.63 |
| 90480 | <1% | 28 | $435.05 | |
| 87210 | <1% | 53 | $293.20 | |
| 86803 | <1% | 12 | $134.85 | |
| 93793 | <1% | 18 | $133.60 | |
| 99177 | <1% | 29 | $126.00 | |
| 36416 | <1% | 60 | $113.82 | |
| 85018 | <1% | 28 | $63.17 | |
| 90647 | <1% | 26 | $37.80 | |
| 90734 | 0% | 39 | $0.00 | |
| 90633 | 0% | 16 | $0.00 | |
| 90723 | 0% | 24 | $0.00 | |
| 90716 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Allina Health System | Saint Paul, MN | $118.02M |
| Allina Health System | Coon Rapids, MN | $22.13M |
| Allina Health System | Minneapolis, MN | $18.26M |
| Allina Health System | Cambridge, MN | $13.17M |
| Allina Health System | St Paul, MN | $10.77M |
| Allina Health System | Faribault, MN | $7.56M |
| Allina Health System | New Ulm, MN | $7.47M |
| Allina Health System | Fridley, MN | $7.34M |
| Allina Health System | Woodbury, MN | $5.49M |
| Allina Health System | Minneapolis, MN | $5.35M |
| Allina Health System | Bloomington, MN | $4.38M |
| Allina Health System | Northfield, MN | $4.36M |
| Allina Health System | Maplewood, MN | $4.15M |
| Allina Health System | West St Paul, MN | $3.64M |
| Allina Health System | Cottage Grove, MN | $3.63M |
| Allina Health System | Minneapolis, MN | $3.54M |
| Allina Health System | Eagan, MN | $3.39M |
| Allina Health System | St Paul, MN | $3.35M |
| Allina Health System | Shakopee, MN | $2.81M |
| Allina Health System | Eden Prairie, MN | $2.71M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.